Allan Klein, MD

Appointed
1989

Education & Fellowships

Fellowship - Mayo Clinic
Cardiovascular Diseases
Rochester, MN
1988

Residency - University of Ottawa Heart Institute
Cardiology
Ottawa, Ontario,
1986

Residency - Royal Victoria Hospital
Internal Medicine
Montreal, Quebec,
1984

Internship - Mount Sinai Hospital
Internal Medicine
Toronto, Ontario,
1982

Medical Education - McGill University Faculty of Medicine
Montreal, QC Canada
1981

Undergraduate - McGill University
Montreal, Quebec,
1977

Additional Training

• Leading in health care business program, Cleveland Clinic

Professional Highlights

• Past three years:

  Notification “In the Spotlight” column of the Cleveland Clinic Professional Staff Update announced the recent appointment of Vice President of the ASE.  After a one-year term, president-elect and then president , 2014
• Invited Visiting Professor at Mount Sinai Hospital for Anandi L. Sharma Visiting Professorship and Simon Dack, MD Memorial Lecture, Heart Failure with Preserved Ejection Fraction with live presentation at www.heart-talks.org, 2015
• 13th Annual Tajik/Seward Lectureship, Cleveland Clinic HVI National Leadership  and Diseases Center and IPU Development, 2015
• Section Editor for Pericardial Disease for ACC.org, 2016
• Key Note Speaker:  “Constrictive Pericarditis in the 21st Century” at the Portuguese Congress of Cardiology, 2016
• Elected President of the American Society of Echocardiography, 2017
• Notification in the Cleveland Clinic “Weekly Scoop:  News from the Chief of Staff 5 Questions section on providing a one-stop-shop for patients with pericardial disease, 2017
  Physician’s Weekly article, “Key Concepts in Managing Complicated Pericarditis”  2017
• Guest Co-Editor for Progress in Cardiovascular Disease 2017;59(4):325-26,  2017
• Co-Editor of “Clinical Echocardiography Review:  A Self-Assessment Tool.” 2nd Edition.  Wolters Kluwer, 2017

Certifications

• Internal Medicine
• Internal Medicine - Cardiovascular Disease

Specialty Interests

Amyloidosis, Heart Valve Disease, Pericardial Disease, Pericarditis, Cardiovascular imaging, Echocardiogram, Non-invasive Diagnostic Testing

Awards & Honors

• Fellowships: American College of Cardiology, Royal College of Physicians (Canada), American Society of Echocardiography, American Heart Association, European Society of Cardiology
• Mentor for the winner of the Laeneec Young Clinician Award at the American Heart Association Scientific Sessions,  2008
• Guideline Chair, American Society of Echocardiography Clinical for Multimodality Cardiovascular Imaging of Patients with Pericardial Disease, 2013
• Invited Visiting Professor at Mount Sinai Hospital for Anandi L. Sharma Visiting Professorship and Simon Dack, MD Memorial Lecture, Heart Failure with Preserved Ejection Fraction with live presentation at www.heart-talks.org, 2015
• 13th Annual Tajik/Seward Lectureship, Cleveland Clinic HVI National Leadership and Diseases Center and IPU Development, 2015
• Section Editor for Pericardial Disease for ACC.org., 2016
• Elected President of the American Society of Echocardiography, 2017
• Guest Co-Editor for Progress in Cardiovascular Disease 2017;59(4):325-26, 2017
• Co-Editor of “Clinical Echocardiography Review:  A Self-Assessment Tool.” 2nd Edition.  Wolters Kluwer, 2017
• Co-Editor of “Diastology:  Clinical Approach to Diastolic Heart Failure.”  Saunders Elsevier, Philadelphia, 2018

Innovations & Patents

• Dr. Klein has pioneered the use of transesophageal-guided cardioversion in patients with atrial fibrillation in his landmark paper in the New England Journal of Medicine published in 2001 and the European Heart Journal in 2006. 
  
  He directs the largest pericardial center in the world which evaluates complex patients with different pericardial diseases.

Memberships

• American Society of Echocardiography
• American Heart Association
• American College of Cardiology
• Royal College of Physicians of Canada
• Society of Cardiovascular Computed Tomography

See publications for Allan Klein, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/31/2024, Dr. Klein has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Klein receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Pfizer, Inc.
• Kiniksa Pharmaceuticals Corp.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.